AKT1 and neoplasm: This different receptor behavior can be explained by its higher kinase activity and its ability to activate pro-oncogenic pathways, including the PI3K/Akt/mTOR, and rewire tumor metabolism, thus supporting and enhancing tumor growth in vitro and in vivo [11].